ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,976,625 | +485.9% | 77,363 | +557.6% | 0.00% | – |
| Q2 2023 | $337,392 | +13510.0% | 11,764 | -88.6% | 0.00% | -100.0% |
| Q1 2023 | $2,479 | +253.1% | 103,411 | +149.9% | 0.00% | – |
| Q4 2022 | $702 | -99.7% | 41,387 | +124.2% | 0.00% | – |
| Q3 2022 | $274,000 | -91.5% | 18,461 | -91.0% | 0.00% | -100.0% |
| Q2 2022 | $3,220,000 | -24.3% | 204,596 | +129.7% | 0.00% | -33.3% |
| Q3 2021 | $4,256,000 | -69.3% | 89,075 | -73.5% | 0.00% | -70.0% |
| Q1 2021 | $13,883,000 | +936.8% | 336,138 | +989.1% | 0.01% | +900.0% |
| Q4 2020 | $1,339,000 | +357.0% | 30,865 | +391.8% | 0.00% | – |
| Q2 2020 | $293,000 | -78.5% | 6,276 | -93.7% | 0.00% | -100.0% |
| Q1 2020 | $1,363,000 | – | 100,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |